Quest Diagnostics Incorporated (DGX) vs Revvity Inc. (RVTY)
- Quest Diagnostics Incorporated DGX 235.00 −1.74%
- Revvity Inc. RVTY 152.64 −1.34%
Quest Diagnostics Incorporated and Revvity Inc. are both Diagnostics & Research companies. Quest Diagnostics Incorporated is the larger, with a market value of $26.4B against $17.3B — 1.5× the size. Quest Diagnostics Incorporated trades at the lower P/E: 24.6× against 72.7×. Quest Diagnostics Incorporated grew revenue faster over the last twelve months: 9.87% against 4.05%. Quest Diagnostics Incorporated has the higher net margin (9.15% vs 8.16%) and the higher return on invested capital (7.94% vs 2.38%). Both pay a dividend; Quest Diagnostics Incorporated yields more (1.44% vs 0.23%). Across the 23 metrics below, Quest Diagnostics Incorporated leads on 18 and Revvity Inc. on 5.
Valuation
Profitability
| Metric | DGX | RVTY | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 33.11% | 54.98% | 50.89% |
| Operating margin | 14.10% | 12.32% | (8.57%) |
| Net margin | 9.15% | 8.16% | (6.37%) |
| Free cash flow margin | 11.67% | 19.58% | 0.00% |
| Return on equity | 14.03% | 3.21% | (2.92%) |
| Return on assets | 6.43% | 1.95% | (6.71%) |
| Return on invested capital | 7.94% | 2.38% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack